Skip to content
ESPT
MARKETS / Consumer staples / Pharmacies / AIXN
RETAIL-DRUG STORES AND PROPRIETARY STORES

AiXin Life International, Inc. AIXN

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.5M
▼ 61.1% YoY
$-2.0M
$-2.0M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

We are a Colorado holding company and conduct substantially all of our operations through our operating companies established in the People’s Republic of China, or the PRC. Our focus is on providing health and wellness products to the growing middle class in China. We currently develop, manufacture, market and sell premium-quality healthcare, nutritional products and wellness supplements, including herbs and greens, traditional Chinese remedies, functional products, such as weight management products, probiotics, foods and drinks. In September 2022, we acquired Yunnan Runcangsheng which engages in the research, development, manufacture and wholesale distribution of health and wellness products. Our pharmacies offer a wide variety of personal healthcare products and traditional Chinese remedies in addition to our health and wellness products.

Written from the business description in AiXin Life International, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 15 May 2026. Every sentence was checked against that document before publication.

Growth

USD 1.5M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 1.5 · Net income -2.0
1.5M3.0M-2.5M-5.0M
201020132016201920222025
Compound annual growth
−18.1%
−9.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −9.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−137 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -169.2% · Net -137.1%
-200%-400%-600%
201020172025
ROE
FY2021 · ROE -4.1%
5%10%15%-50%-100%
201020172025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.
Gross margin41.7%
Operating margin-169.2%
Net margin-137.1%
EBITDAUSD -2.4M

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -2.0
1M2M-1M-2M
201020172025
Dividends paid·
Net buybacks·
Share of profit·
Consecutive raises·

Total assetsUSD 3.2M
EquityUSD -6.6M
CashUSD 20,751.00
Gross debtUSD 85,799.00
Net debtUSD 65,048.00
Current ratio0.12×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 16-year record

16 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
AIXN, 16-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.0◌0.00.00.0◌◌
Operating income $B−0.0−0.0−0.0−0.0−0.00.00.0−0.0−0.0−0.0◌−0.0−0.0◌◌◌
EBITDA $B−0.0−0.0−0.0−0.00.00.00.0−0.0−0.0−0.0◌◌◌◌◌◌
Income tax $B0.00.00.00.00.00.0◌◌◌◌◌0.00.00.0−0.0−0.0
Net income $B−0.0−0.0−0.0−0.0−0.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0◌◌◌◌◌◌
EPS, diluted $−0.08−0.11−0.08−0.26−0.010.020.03−0.00−0.01−0.01−0.00−0.00−0.00−0.00−0.00−0.00
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————————
ROE %————−4.117.0—————————−129.3
Shares out B0.020.020.020.020.050.050.340.290.290.050.05◌◌◌0.050.05

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

Compare

This company against its peers

AiXin Life International, Inc.vsCVS Health Corp.Same industry: Retail-Drug Stores and Proprietary StoresAiXin Life International, Inc.vsPetmed Express Inc.Same industry: Retail-Drug Stores and Proprietary StoresAiXin Life International, Inc.vsRidgetech Inc.Same industry: Retail-Drug Stores and Proprietary StoresAiXin Life International, Inc.vsTrees Corp. (Colorado)Same industry: Retail-Drug Stores and Proprietary Stores
More in this sector

Other companies filing in the same sector

CVS · KR · PEP · JBS · SYY · ACI
Provenance

Company facts, as filed

How we verify · 0 failures in 62 reconciliationsAUDITED

Reconciled in 16 of the 16 fiscal years we could check. Nine checks were skipped: cost of revenue is not tagged before 2016. Six checks were skipped: the balance sheet is not tagged before 2010. Four checks were skipped: the share count is not tagged before 2011.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityRetail-Drug Stores and Proprietary Stores
Listed onnot stated in the filings
Incorporated inColorado
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2010

Share this section

Download image